ENTOS

entos-logo

Entos is a software and web agency that develops websites for e-commerce solutions.

#SimilarOrganizations #Website #More

ENTOS

Social Links:

Industry:
E-Commerce Information Technology Software Web Development

Founded:
1999-01-01

Address:
Lidköping, Vastra Gotaland, Sweden

Country:
Sweden

Website Url:
http://www.entos.se

Total Employee:
1+

Status:
Active

Contact:
46-510-26990

Email Addresses:
[email protected]

Technology used in webpage:
LetsEncrypt Apache Mobile Non Scaleable Content Contact Form 7 Gravatar Profiles ASP.NET Apple Mobile Web App Capable IIS Apache 2.4 Sectigo SSL


Similar Organizations

just-systems-logo

Just Systems

Just Systems provides a range of web services including website design and e-commerce solutions.

Official Site Inspections

http://www.entos.se

  • Host name: website-proxy.ilait.se
  • IP address: 185.15.121.100
  • Location: Sweden
  • Latitude: 59.3247
  • Longitude: 18.056
  • Timezone: Europe/Stockholm

Loading ...

More informations about "Entos"

Entos - Crunchbase Company Profile & Funding

Organization. Entos . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number 46-510-26990; Lists …See details»

Entos Pharmaceuticals

Entos Pharmaceuticals UK. European Headquarters: 33 St. James's Square, Westminster, London, SW1Y 4JS, United Kingdom. Get directions. Telephone & Email Addresses. Tel: 1 …See details»

Entos Pharmaceuticals - Crunchbase Company Profile …

Organization. Entos Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Entos Pharmaceuticals is a clinical-stage biotech company developing genetic …See details»

Entos | Company Overview & News - Forbes

Entos closed a $53 million Series A financing round in June 2021 led by Coatue and biomedical technology investor Catalio Capital Management. Its scientific advisory board includes Nobel …See details»

Entos (Biotechnology) Company Profile 2024: …

Entos (Biotechnology) General Information Description. Developer of a nucleic acid-based therapy designed to treat cancer. The company's therapy uses a novel mechanism of action to deliver molecules, intact and unmodified, …See details»

Lilly and Entos Pharmaceuticals Enter into Research and …

Jan 6, 2022 Entos will receive an initial payment of $50 million, which includes an equity investment by Lilly in Entos. For each of the programs under the collaboration, Entos is also …See details»

Entos Pharmaceuticals Receives Approval from Health Canada to …

Jun 10, 2024 EDMONTON, Alberta & SAN DIEGO, June 10, 2024--Entos Pharmaceuticals (Entos or the Company), a clinical-stage biotechnology company developing genetic …See details»

Entos Raises $53 Million Series A Round Led by Coatue …

Jul 14, 2021 Entos, Inc (“Entos” or “the Company”), the creator of a cutting-edge platform combining AI-driven technology and automated synthetic development to de Entos Raises $53 Million Series A ...See details»

Entos Pharmaceuticals - Craft

Entos Pharmaceuticals is a company that develops nucleic acid-based therapies using its proprietary Fusogenix drug delivery system. Its mechanism of action delivers molecules, intact …See details»

Entos Raises $53 Million Series A Round Led by Coatue and Catalio

Jul 14, 2021 SAN DIEGO--(BUSINESS WIRE)-- Entos, Inc (“Entos” or “the Company”), the creator of a cutting-edge platform combining AI-driven technology and automated synthetic …See details»

With Lilly on board, Entos' medical chief champions genetic …

Apr 14, 2022 Entos Pharmaceuticals is on the verge of "leveling up," and Steve Chen is excited to help them get there. "I think the company right now is actually going through what I would …See details»

Entos Announces Scientific Advisory Board Additions

Sep 9, 2021 The additions of Prof. Taunton and Dr. Brameld are the latest in a string of recent milestones since Entos was created, including the Company’s $53 million Series A financing …See details»

Made-in-Edmonton COVID-19 vaccine ready for clinical trials, …

Mar 11, 2021 Funding remains a looming question for Entos. The company has received $9.2 million in support since the summer, including $5 million from the National Research Council …See details»

Entos picks up $53M - PitchBook

Jul 15, 2021 Entos has raised a $53 million Series A co-led by Coatue and Catalio Capital Management.The San Diego-based company uses AI and automated synthetic development …See details»

How Entos’ delivery platform is realizing the untapped ... - Nature

How Entos’ delivery platform is realizing the untapped promise of genetic medicines Unique proteolipid vehicle (PLV) technology developed by Entos Pharmaceuticals is broadening the …See details»

Entos secures $109M partnership to create new inflammatory …

Dec 19, 2019 Entos is aiming to launch a clinical trial at Edmonton’s Cross Cancer Institute in 2020, recruiting patients living with prostate, lung, colorectal or pancreatic cancer. Gene …See details»

Entos Raises $53 Million Series A Round Led by Coatue and Catalio

Jul 14, 2021 SAN DIEGO– Entos, Inc (“Entos” or “the Company”), the creator of a cutting-edge platform combining AI-driven technology and automated synthetic development to design …See details»

How Entos’ delivery platform is realizing the untapped ... - Nature

Entos has used PLVs to develop a fridge-stable, single-shot COVID-19 booster. The DNA PLV vaccine—the first of its kind—is cheaper to make than mRNA LNPs and could provide longer …See details»

Entos | Entos to Develop Open-Source Machine-Learning Tool for …

Nov 30, 2020 Entos Inc., a Pasadena-based startup, aims to provide tools for molecular and materials discovery, through the use of physics-based machine learning. Now, Entos has …See details»

Entos | Envision is released worldwide as Wallace Derricotte joins ...

Mar 31, 2021 Entos has overcome this problem via breakthrough machine-learning algorithms that accelerate simulations by factors of 1000 or greater. The dramatic reductions in simulation …See details»

linkstock.net © 2022. All rights reserved